EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Dissecting Causal Relationships Between Antihypertensive Drug, Gut Microbiota, and Type 2 Diabetes Mellitus and Its Complications: A Mendelian Randomization Study

He Zheng iD, Shiping Wu, Wenbin Wang, Weida Qiu, Yingqing Feng

The Journal of Clinical Hypertension · 2025

DOI: 10.1111/jch.14968 ↗

At a glance

Journal article in The Journal of Clinical Hypertension, 2025. Written by He Zheng and 4 co-authors. Institution: Department of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Aca…. Major MEDLINE topics: Diabetes Mellitus, Type 2, Gastrointestinal Microbiome, Antihypertensive Agents, Hypertension. 34 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: the Key R&D Program of Guangdong Province, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, the Climbing Plan of Guangdong Provincial People's Hospital.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Limited research has investigated the impact of antihypertensive medications on type 2 diabetes mellitus (T2DM) and whether gut microbiome (GM) mediates this association. Thus, we conducted a two‐sample Mendelian randomization (MR) analysis to estimate the potential impact of various antihypertensive drug target genes on T2DM and its complications. Genetic instruments for the expression of antihypertensive drug target genes were identified with expression quantitative trait loci (eQTL) in blood, which should be associated with systolic blood pressure (SBP). Sensitivity analysis, including reverse causality detection, horizontal pleiotropy, phenotype scanning, and Bayesian colocalization, was used to validate our findings. We performed a two‐step MR to detect the mediating role of GM. A 1‐standard deviation (SD) decrease of KCNJ11 (acting on arteriolar smooth muscle, e.g., Pinacidil) gene expression was associated with lower SBP of 1.12 (95% confidence interval [CI], 0.93–1.31) mmHg, and a decreased risk of diabetic retinopathy (odds ratio [OR], 0.63; 95% CI, 0.52–0.76). Similarly, a 1‐SD decrease of SLC12A2 (genetically a proxy for diuretics, for example, Torasemide) gene expression was correlated with a reduced risk of T2DM (OR, 0.88; 95% CI, 0.83–0.92). Interestingly, this causal effect was influenced by a decrease in the gut microbiota abundance of the genus Ruminococcus (effect proportion = 11.2%). Colocalization supports these results (KCNJ11: 98% for diabetic retinopathy; SLC12A2: 99% for T2DM). Findings provide novel targets for the treatment of T2DM and its complications, emphasize the importance of KCNJ11 and SLC12A2 in future drug development, and highlight the significant mediating role of the genus Ruminococcus .

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeAntihypertensive AgentsHypertensionHumansMendelian Randomization AnalysisPotassium Channels, Inwardly RectifyingBlood PressureQuantitative Trait LociDiabetic RetinopathyKcnj11 Channel

Author keywords

Mendelian randomizationantihypertensive drugscomplicationsgut microbiotatype 2 diabetes

Substances

Antihypertensive AgentsPotassium Channels, Inwardly RectifyingKcnj11 Channel

Authors and institutions

  • Department of Cardiology, Hypertension Research Laboratory, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Chi…
  • School of Medicine, South China University of Technology, Guangzhou, China.

ORCID profiles: He Zheng

Funding

  • the Key R&D Program of Guangdong Province
  • Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention
  • the Climbing Plan of Guangdong Provincial People's Hospital
  • the Guangdong Provincial Clinical Research Center for Cardiovascular disease

Cite

APA

Zheng, H., Wu, S., Wang, W., Qiu, W., & Feng, Y. (2025). Dissecting Causal Relationships Between Antihypertensive Drug, Gut Microbiota, and Type 2 Diabetes Mellitus and Its Complications: A Mendelian Randomization Study. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14968

Vancouver

Zheng H, Wu S, Wang W, Qiu W, Feng Y. Dissecting Causal Relationships Between Antihypertensive Drug, Gut Microbiota, and Type 2 Diabetes Mellitus and Its Complications: A Mendelian Randomization Study. The Journal of Clinical Hypertension. 2025. doi:10.1111/jch.14968

BibTeX
@article{Zheng2025,
  author = {Zheng, He and Wu, Shiping and Wang, Wenbin and Qiu, Weida and Feng, Yingqing},
  title = {Dissecting Causal Relationships Between Antihypertensive Drug, Gut Microbiota, and Type 2 Diabetes Mellitus and Its Complications: A Mendelian Randomization Study},
  journal = {The Journal of Clinical Hypertension},
  year = {2025},
  doi = {10.1111/jch.14968}
}
Start for free →